To our knowledge, only one cross-sectional study has previously analyzed CXCL16 levels in MS patients, reporting higher levels in CSF compared to serum and higher levels in patients with MS and other inflammatory CNS diseases compared to controls with non-inflammatory neurological diseases [18]. The gene discussed is CXCL16; the disease is myeloid sarcoma.